LANREOTIDE Pharmacologic Class Indexing
- Class set ID
- efcf1876-565d-4394-a9b9-398da2938958
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use LANREOTIDE INJECTION safely and effectively. See full prescribing information for LANREOTIDE INJECTION. LANREOTIDE injection, for subcutaneous use Initial U.S. Approval: 2007 | Cipla USA Inc. | InvaGen Pharmaceuticals, Inc. | Pharmathen International S.A. | 20250201 | 3 |
| These highlights do not include all the information needed to use LANREOTIDE INJECTION safely and effectively. See full prescribing information for LANREOTIDE INJECTION. LANREOTIDE injection, for subcutaneous use Initial U.S. Approval: 2007 | EXELAN PHARMACEUTICALS, INC. | INVAGEN PHARMACEUTICALS, INC. | Pharmathen International S.A | 20250201 | 2 |
| These highlights do not include all the information needed to use SOMATULINE DEPOT safely and effectively. See full prescribing information for SOMATULINE DEPOT. SOMATULINE ® DEPOT (lanreotide) injection, for subcutaneous use Initial U.S. Approval: 2007 | Ipsen Biopharmaceuticals, Inc. | IPSEN PHARMA BIOTECH | 20241011 | 16 |
| These highlights do not include all the information needed to use LANREOTIDE INJECTION safely and effectively. See full prescribing information for LANREOTIDE INJECTION. LANREOTIDE injection, for subcutaneous use Initial U.S. Approval: 2007 | Cipla USA Inc. | InvaGen Pharmaceuticals, Inc. | Pharmathen International S.A. | 20240901 | 7 |